C.Q. Pharmaceutical Holding Co., Ltd. (000950) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

C.Q. Pharmaceutical Holding Co., Ltd.

Why is C.Q. Pharmaceutical Holding Co., Ltd. ?

High Debt Company with a Debt to Equity ratio (avg) at times

Poor long term growth as Net Sales has grown by an annual rate of 18.76% and Operating profit at -0.04% over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times
The company has been able to generate a Return on Equity (avg) of 9.37% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 18.76% and Operating profit at -0.04% over the last 5 years

Flat results in Mar 25

NET PROFIT(HY) At CNY 116.75 MM has Grown at -48.74%
ROCE(HY) Lowest at 2.68%
DEBT-EQUITY RATIO (HY) Highest at 181.53 %

With ROE of 3.91%, it has a attractive valuation with a 0.76 Price to Book Value

Over the past year, while the stock has generated a return of -4.48%, its profits have fallen by -4.9%
At the current price, the company has a high dividend yield of 1.2

Below par performance in long term as well as near term

Along with generating -4.48% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in the last 3 years, 1 year and 3 months

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to C.Q. Pharmaceutical Holding Co., Ltd. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is C.Q. Pharmaceutical Holding Co., Ltd. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

C.Q. Pharmaceutical Holding Co., Ltd.

-6.97%

0.12

24.47%

China Shanghai Composite

14.77%

1.01

15.10%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

18.76%

EBIT Growth (5y)

-0.04%

EBIT to Interest (avg)

1.75

Debt to EBITDA (avg)

8.31

Net Debt to Equity (avg)

1.79

Sales to Capital Employed (avg)

2.05

Tax Ratio

73.33%

Dividend Payout Ratio

36.63%

Pledged Shares

Institutional Holding

ROCE (avg)

6.77%

ROE (avg)

9.37%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.76

EV to EBIT

26.11

EV to EBITDA

17.43

EV to Capital Employed

0.92

EV to Sales

0.38

PEG Ratio

Dividend Yield

1.18%

ROCE (Latest)

3.52%

ROE (Latest)

3.91%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bullish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

9What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 865.94 MM

PRE-TAX PROFIT(Q)

At CNY 138.83 MM has Grown at 260.84%

RAW MATERIAL COST(Y)

Fallen by 0.83% (YoY

CASH AND EQV(HY)

Highest at CNY 16,365.61 MM

NET PROFIT(Q)

At CNY 125.85 MM has Grown at 81.81%

-11What is not working for the Company

NET PROFIT(HY)

At CNY 116.75 MM has Grown at -48.74%

ROCE(HY)

Lowest at 2.68%

DEBT-EQUITY RATIO (HY)

Highest at 181.53 %

INVENTORY TURNOVER RATIO(HY)

Lowest at 8.34%

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.11%

Here's what is working for C.Q. Pharmaceutical Holding Co., Ltd.

Pre-Tax Profit

At CNY 138.83 MM has Grown at 260.84%

over average net sales of the previous four periods of CNY 38.48 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Operating Cash Flow

Highest at CNY 865.94 MM and Grown

In each year in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Net Profit

At CNY 125.85 MM has Grown at 81.81%

over average net sales of the previous four periods of CNY 69.22 MM

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

Cash and Eqv

Highest at CNY 16,365.61 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is improving

Cash and Cash Equivalents

Raw Material Cost

Fallen by 0.83% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for C.Q. Pharmaceutical Holding Co., Ltd.

Debt-Equity Ratio

Highest at 181.53 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Inventory Turnover Ratio

Lowest at 8.34%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Debtors Turnover Ratio

Lowest at 2.11%

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio